Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Oramed Pharmaceuticals (ORMP) has provided an announcement.
David Silberman has stepped down from his roles as CFO, Treasurer, and Secretary at Oramed Pharmaceuticals Inc. for personal reasons, with his resignation effective from July 12, 2024. The company is actively looking for a new CFO to fill the vacancy.
Find detailed analytics on ORMP stock on TipRanks’ Stock Analysis page.